Request Free Sample ×
Serological Testing Market Research Report - Global Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Serological Testing Market

ID: MRFR/HC/41804-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Serological Testing Market Research Report: Size, Share, Trend Analysis By Test Type (Enzyme-Linked Immunosorbent Assay, Western Blot, Radioimmunoassay, Immunofluorescence Assay), By Applications (Infectious Diseases, Autoimmune Disorders, Transplant Rejection, Blood Donations Screening), By End Users (Clinical Laboratories, Hospitals, Diagnostic Centers, Research Institutions), By Technology (Traditional Serological Testing, Point-of-Care Testing, Microfluidics Technology) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Serological Testing Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Enzyme-Linked Immunosorbent Assay
  50.     4.1.2 Western Blot
  51.     4.1.3 Radioimmunoassay
  52.     4.1.4 Immunofluorescence Assay
  53.   4.2 Healthcare, BY Application (USD Billion)
  54.     4.2.1 Infectious Diseases
  55.     4.2.2 Autoimmune Disorders
  56.     4.2.3 Transplant Rejection
  57.     4.2.4 Blood Donations Screening
  58.   4.3 Healthcare, BY End User (USD Billion)
  59.     4.3.1 Clinical Laboratories
  60.     4.3.2 Hospitals
  61.     4.3.3 Diagnostic Centers
  62.     4.3.4 Research Institutions
  63.   4.4 Healthcare, BY Technology (USD Billion)
  64.     4.4.1 Traditional Serological Testing
  65.     4.4.2 Point-of-Care Testing
  66.     4.4.3 Microfluidics Technology
  67.   4.5 Healthcare, BY Region (USD Billion)
  68.     4.5.1 North America
  69.       4.5.1.1 US
  70.       4.5.1.2 Canada
  71.     4.5.2 Europe
  72.       4.5.2.1 Germany
  73.       4.5.2.2 UK
  74.       4.5.2.3 France
  75.       4.5.2.4 Russia
  76.       4.5.2.5 Italy
  77.       4.5.2.6 Spain
  78.       4.5.2.7 Rest of Europe
  79.     4.5.3 APAC
  80.       4.5.3.1 China
  81.       4.5.3.2 India
  82.       4.5.3.3 Japan
  83.       4.5.3.4 South Korea
  84.       4.5.3.5 Malaysia
  85.       4.5.3.6 Thailand
  86.       4.5.3.7 Indonesia
  87.       4.5.3.8 Rest of APAC
  88.     4.5.4 South America
  89.       4.5.4.1 Brazil
  90.       4.5.4.2 Mexico
  91.       4.5.4.3 Argentina
  92.       4.5.4.4 Rest of South America
  93.     4.5.5 MEA
  94.       4.5.5.1 GCC Countries
  95.       4.5.5.2 South Africa
  96.       4.5.5.3 Rest of MEA
  97. 5 SECTION V: COMPETITIVE ANALYSIS
  98.   5.1 Competitive Landscape
  99.     5.1.1 Overview
  100.     5.1.2 Competitive Analysis
  101.     5.1.3 Market share Analysis
  102.     5.1.4 Major Growth Strategy in the Healthcare
  103.     5.1.5 Competitive Benchmarking
  104.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  105.     5.1.7 Key developments and growth strategies
  106.       5.1.7.1 New Product Launch/Service Deployment
  107.       5.1.7.2 Merger & Acquisitions
  108.       5.1.7.3 Joint Ventures
  109.     5.1.8 Major Players Financial Matrix
  110.       5.1.8.1 Sales and Operating Income
  111.       5.1.8.2 Major Players R&D Expenditure. 2023
  112.   5.2 Company Profiles
  113.     5.2.1 Abbott Laboratories (US)
  114.       5.2.1.1 Financial Overview
  115.       5.2.1.2 Products Offered
  116.       5.2.1.3 Key Developments
  117.       5.2.1.4 SWOT Analysis
  118.       5.2.1.5 Key Strategies
  119.     5.2.2 Roche Diagnostics (CH)
  120.       5.2.2.1 Financial Overview
  121.       5.2.2.2 Products Offered
  122.       5.2.2.3 Key Developments
  123.       5.2.2.4 SWOT Analysis
  124.       5.2.2.5 Key Strategies
  125.     5.2.3 Siemens Healthineers (DE)
  126.       5.2.3.1 Financial Overview
  127.       5.2.3.2 Products Offered
  128.       5.2.3.3 Key Developments
  129.       5.2.3.4 SWOT Analysis
  130.       5.2.3.5 Key Strategies
  131.     5.2.4 Thermo Fisher Scientific (US)
  132.       5.2.4.1 Financial Overview
  133.       5.2.4.2 Products Offered
  134.       5.2.4.3 Key Developments
  135.       5.2.4.4 SWOT Analysis
  136.       5.2.4.5 Key Strategies
  137.     5.2.5 Ortho Clinical Diagnostics (US)
  138.       5.2.5.1 Financial Overview
  139.       5.2.5.2 Products Offered
  140.       5.2.5.3 Key Developments
  141.       5.2.5.4 SWOT Analysis
  142.       5.2.5.5 Key Strategies
  143.     5.2.6 bioMérieux (FR)
  144.       5.2.6.1 Financial Overview
  145.       5.2.6.2 Products Offered
  146.       5.2.6.3 Key Developments
  147.       5.2.6.4 SWOT Analysis
  148.       5.2.6.5 Key Strategies
  149.     5.2.7 Quidel Corporation (US)
  150.       5.2.7.1 Financial Overview
  151.       5.2.7.2 Products Offered
  152.       5.2.7.3 Key Developments
  153.       5.2.7.4 SWOT Analysis
  154.       5.2.7.5 Key Strategies
  155.     5.2.8 Hologic, Inc. (US)
  156.       5.2.8.1 Financial Overview
  157.       5.2.8.2 Products Offered
  158.       5.2.8.3 Key Developments
  159.       5.2.8.4 SWOT Analysis
  160.       5.2.8.5 Key Strategies
  161.   5.3 Appendix
  162.     5.3.1 References
  163.     5.3.2 Related Reports
  164. 6 LIST OF FIGURES
  165.   6.1 MARKET SYNOPSIS
  166.   6.2 NORTH AMERICA MARKET ANALYSIS
  167.   6.3 US MARKET ANALYSIS BY TYPE
  168.   6.4 US MARKET ANALYSIS BY APPLICATION
  169.   6.5 US MARKET ANALYSIS BY END USER
  170.   6.6 US MARKET ANALYSIS BY TECHNOLOGY
  171.   6.7 CANADA MARKET ANALYSIS BY TYPE
  172.   6.8 CANADA MARKET ANALYSIS BY APPLICATION
  173.   6.9 CANADA MARKET ANALYSIS BY END USER
  174.   6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY
  175.   6.11 EUROPE MARKET ANALYSIS
  176.   6.12 GERMANY MARKET ANALYSIS BY TYPE
  177.   6.13 GERMANY MARKET ANALYSIS BY APPLICATION
  178.   6.14 GERMANY MARKET ANALYSIS BY END USER
  179.   6.15 GERMANY MARKET ANALYSIS BY TECHNOLOGY
  180.   6.16 UK MARKET ANALYSIS BY TYPE
  181.   6.17 UK MARKET ANALYSIS BY APPLICATION
  182.   6.18 UK MARKET ANALYSIS BY END USER
  183.   6.19 UK MARKET ANALYSIS BY TECHNOLOGY
  184.   6.20 FRANCE MARKET ANALYSIS BY TYPE
  185.   6.21 FRANCE MARKET ANALYSIS BY APPLICATION
  186.   6.22 FRANCE MARKET ANALYSIS BY END USER
  187.   6.23 FRANCE MARKET ANALYSIS BY TECHNOLOGY
  188.   6.24 RUSSIA MARKET ANALYSIS BY TYPE
  189.   6.25 RUSSIA MARKET ANALYSIS BY APPLICATION
  190.   6.26 RUSSIA MARKET ANALYSIS BY END USER
  191.   6.27 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
  192.   6.28 ITALY MARKET ANALYSIS BY TYPE
  193.   6.29 ITALY MARKET ANALYSIS BY APPLICATION
  194.   6.30 ITALY MARKET ANALYSIS BY END USER
  195.   6.31 ITALY MARKET ANALYSIS BY TECHNOLOGY
  196.   6.32 SPAIN MARKET ANALYSIS BY TYPE
  197.   6.33 SPAIN MARKET ANALYSIS BY APPLICATION
  198.   6.34 SPAIN MARKET ANALYSIS BY END USER
  199.   6.35 SPAIN MARKET ANALYSIS BY TECHNOLOGY
  200.   6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
  201.   6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  202.   6.38 REST OF EUROPE MARKET ANALYSIS BY END USER
  203.   6.39 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
  204.   6.40 APAC MARKET ANALYSIS
  205.   6.41 CHINA MARKET ANALYSIS BY TYPE
  206.   6.42 CHINA MARKET ANALYSIS BY APPLICATION
  207.   6.43 CHINA MARKET ANALYSIS BY END USER
  208.   6.44 CHINA MARKET ANALYSIS BY TECHNOLOGY
  209.   6.45 INDIA MARKET ANALYSIS BY TYPE
  210.   6.46 INDIA MARKET ANALYSIS BY APPLICATION
  211.   6.47 INDIA MARKET ANALYSIS BY END USER
  212.   6.48 INDIA MARKET ANALYSIS BY TECHNOLOGY
  213.   6.49 JAPAN MARKET ANALYSIS BY TYPE
  214.   6.50 JAPAN MARKET ANALYSIS BY APPLICATION
  215.   6.51 JAPAN MARKET ANALYSIS BY END USER
  216.   6.52 JAPAN MARKET ANALYSIS BY TECHNOLOGY
  217.   6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
  218.   6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  219.   6.55 SOUTH KOREA MARKET ANALYSIS BY END USER
  220.   6.56 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
  221.   6.57 MALAYSIA MARKET ANALYSIS BY TYPE
  222.   6.58 MALAYSIA MARKET ANALYSIS BY APPLICATION
  223.   6.59 MALAYSIA MARKET ANALYSIS BY END USER
  224.   6.60 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
  225.   6.61 THAILAND MARKET ANALYSIS BY TYPE
  226.   6.62 THAILAND MARKET ANALYSIS BY APPLICATION
  227.   6.63 THAILAND MARKET ANALYSIS BY END USER
  228.   6.64 THAILAND MARKET ANALYSIS BY TECHNOLOGY
  229.   6.65 INDONESIA MARKET ANALYSIS BY TYPE
  230.   6.66 INDONESIA MARKET ANALYSIS BY APPLICATION
  231.   6.67 INDONESIA MARKET ANALYSIS BY END USER
  232.   6.68 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
  233.   6.69 REST OF APAC MARKET ANALYSIS BY TYPE
  234.   6.70 REST OF APAC MARKET ANALYSIS BY APPLICATION
  235.   6.71 REST OF APAC MARKET ANALYSIS BY END USER
  236.   6.72 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
  237.   6.73 SOUTH AMERICA MARKET ANALYSIS
  238.   6.74 BRAZIL MARKET ANALYSIS BY TYPE
  239.   6.75 BRAZIL MARKET ANALYSIS BY APPLICATION
  240.   6.76 BRAZIL MARKET ANALYSIS BY END USER
  241.   6.77 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
  242.   6.78 MEXICO MARKET ANALYSIS BY TYPE
  243.   6.79 MEXICO MARKET ANALYSIS BY APPLICATION
  244.   6.80 MEXICO MARKET ANALYSIS BY END USER
  245.   6.81 MEXICO MARKET ANALYSIS BY TECHNOLOGY
  246.   6.82 ARGENTINA MARKET ANALYSIS BY TYPE
  247.   6.83 ARGENTINA MARKET ANALYSIS BY APPLICATION
  248.   6.84 ARGENTINA MARKET ANALYSIS BY END USER
  249.   6.85 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
  250.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  251.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  252.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
  253.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
  254.   6.90 MEA MARKET ANALYSIS
  255.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  256.   6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  257.   6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER
  258.   6.94 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
  259.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  260.   6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  261.   6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER
  262.   6.98 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
  263.   6.99 REST OF MEA MARKET ANALYSIS BY TYPE
  264.   6.100 REST OF MEA MARKET ANALYSIS BY APPLICATION
  265.   6.101 REST OF MEA MARKET ANALYSIS BY END USER
  266.   6.102 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
  267.   6.103 KEY BUYING CRITERIA OF HEALTHCARE
  268.   6.104 RESEARCH PROCESS OF MRFR
  269.   6.105 DRO ANALYSIS OF HEALTHCARE
  270.   6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  271.   6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  272.   6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
  273.   6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  274.   6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  275.   6.111 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  276.   6.112 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  277.   6.113 HEALTHCARE, BY END USER, 2024 (% SHARE)
  278.   6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
  279.   6.115 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  280.   6.116 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  281.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  282. 7 LIST OF TABLES
  283.   7.1 LIST OF ASSUMPTIONS
  284.     7.1.1
  285.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  286.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  287.     7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  288.     7.2.3 BY END USER, 2025-2035 (USD Billion)
  289.     7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  290.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  291.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  292.     7.3.2 BY APPLICATION, 2025-2035 (USD Billion)
  293.     7.3.3 BY END USER, 2025-2035 (USD Billion)
  294.     7.3.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  295.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  296.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  297.     7.4.2 BY APPLICATION, 2025-2035 (USD Billion)
  298.     7.4.3 BY END USER, 2025-2035 (USD Billion)
  299.     7.4.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  300.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  301.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  302.     7.5.2 BY APPLICATION, 2025-2035 (USD Billion)
  303.     7.5.3 BY END USER, 2025-2035 (USD Billion)
  304.     7.5.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  305.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  306.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  307.     7.6.2 BY APPLICATION, 2025-2035 (USD Billion)
  308.     7.6.3 BY END USER, 2025-2035 (USD Billion)
  309.     7.6.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  310.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  311.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  312.     7.7.2 BY APPLICATION, 2025-2035 (USD Billion)
  313.     7.7.3 BY END USER, 2025-2035 (USD Billion)
  314.     7.7.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  315.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  316.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  317.     7.8.2 BY APPLICATION, 2025-2035 (USD Billion)
  318.     7.8.3 BY END USER, 2025-2035 (USD Billion)
  319.     7.8.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  320.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  321.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  322.     7.9.2 BY APPLICATION, 2025-2035 (USD Billion)
  323.     7.9.3 BY END USER, 2025-2035 (USD Billion)
  324.     7.9.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  325.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  326.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  327.     7.10.2 BY APPLICATION, 2025-2035 (USD Billion)
  328.     7.10.3 BY END USER, 2025-2035 (USD Billion)
  329.     7.10.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  330.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  331.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  332.     7.11.2 BY APPLICATION, 2025-2035 (USD Billion)
  333.     7.11.3 BY END USER, 2025-2035 (USD Billion)
  334.     7.11.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  335.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  336.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  337.     7.12.2 BY APPLICATION, 2025-2035 (USD Billion)
  338.     7.12.3 BY END USER, 2025-2035 (USD Billion)
  339.     7.12.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  340.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  341.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  342.     7.13.2 BY APPLICATION, 2025-2035 (USD Billion)
  343.     7.13.3 BY END USER, 2025-2035 (USD Billion)
  344.     7.13.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  345.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  346.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  347.     7.14.2 BY APPLICATION, 2025-2035 (USD Billion)
  348.     7.14.3 BY END USER, 2025-2035 (USD Billion)
  349.     7.14.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  350.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  351.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  352.     7.15.2 BY APPLICATION, 2025-2035 (USD Billion)
  353.     7.15.3 BY END USER, 2025-2035 (USD Billion)
  354.     7.15.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  355.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  356.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  357.     7.16.2 BY APPLICATION, 2025-2035 (USD Billion)
  358.     7.16.3 BY END USER, 2025-2035 (USD Billion)
  359.     7.16.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  360.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  361.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  362.     7.17.2 BY APPLICATION, 2025-2035 (USD Billion)
  363.     7.17.3 BY END USER, 2025-2035 (USD Billion)
  364.     7.17.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  365.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  366.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  367.     7.18.2 BY APPLICATION, 2025-2035 (USD Billion)
  368.     7.18.3 BY END USER, 2025-2035 (USD Billion)
  369.     7.18.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  370.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  371.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  372.     7.19.2 BY APPLICATION, 2025-2035 (USD Billion)
  373.     7.19.3 BY END USER, 2025-2035 (USD Billion)
  374.     7.19.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  375.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  376.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  377.     7.20.2 BY APPLICATION, 2025-2035 (USD Billion)
  378.     7.20.3 BY END USER, 2025-2035 (USD Billion)
  379.     7.20.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  380.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  381.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  382.     7.21.2 BY APPLICATION, 2025-2035 (USD Billion)
  383.     7.21.3 BY END USER, 2025-2035 (USD Billion)
  384.     7.21.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  385.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  386.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  387.     7.22.2 BY APPLICATION, 2025-2035 (USD Billion)
  388.     7.22.3 BY END USER, 2025-2035 (USD Billion)
  389.     7.22.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  390.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  391.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  392.     7.23.2 BY APPLICATION, 2025-2035 (USD Billion)
  393.     7.23.3 BY END USER, 2025-2035 (USD Billion)
  394.     7.23.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  395.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  396.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  397.     7.24.2 BY APPLICATION, 2025-2035 (USD Billion)
  398.     7.24.3 BY END USER, 2025-2035 (USD Billion)
  399.     7.24.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  400.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  401.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  402.     7.25.2 BY APPLICATION, 2025-2035 (USD Billion)
  403.     7.25.3 BY END USER, 2025-2035 (USD Billion)
  404.     7.25.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  405.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  406.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  407.     7.26.2 BY APPLICATION, 2025-2035 (USD Billion)
  408.     7.26.3 BY END USER, 2025-2035 (USD Billion)
  409.     7.26.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  410.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  411.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  412.     7.27.2 BY APPLICATION, 2025-2035 (USD Billion)
  413.     7.27.3 BY END USER, 2025-2035 (USD Billion)
  414.     7.27.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  415.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  416.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  417.     7.28.2 BY APPLICATION, 2025-2035 (USD Billion)
  418.     7.28.3 BY END USER, 2025-2035 (USD Billion)
  419.     7.28.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  420.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  421.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  422.     7.29.2 BY APPLICATION, 2025-2035 (USD Billion)
  423.     7.29.3 BY END USER, 2025-2035 (USD Billion)
  424.     7.29.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  425.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  426.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  427.     7.30.2 BY APPLICATION, 2025-2035 (USD Billion)
  428.     7.30.3 BY END USER, 2025-2035 (USD Billion)
  429.     7.30.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
  430.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  431.     7.31.1
  432.   7.32 ACQUISITION/PARTNERSHIP
  433.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Enzyme-Linked Immunosorbent Assay
  • Western Blot
  • Radioimmunoassay
  • Immunofluorescence Assay

Healthcare By Application (USD Billion, 2025-2035)

  • Infectious Diseases
  • Autoimmune Disorders
  • Transplant Rejection
  • Blood Donations Screening

Healthcare By End User (USD Billion, 2025-2035)

  • Clinical Laboratories
  • Hospitals
  • Diagnostic Centers
  • Research Institutions

Healthcare By Technology (USD Billion, 2025-2035)

  • Traditional Serological Testing
  • Point-of-Care Testing
  • Microfluidics Technology

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓